Catalyst
Slingshot members are tracking this event:
Kite Primary Analysis of ZUMA-1 Trial Evaluating KTE-C19 in Aggressive Non-Hodgkin Lymphoma
- Source Link:
- http://ir.kitepharma.com/events.cfm
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
KITE |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 28, 2017
Occurred Source:
http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=1014817
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Primary Analysis, Zuma-1, Kte-c19, Aggressive Non-hodgkin Lymphoma